2025-2034 Pertussis Vaccine Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Pertussis Vaccine Market Size By 2025?
In the past few years, the size of the pertussis vaccine market has experienced consistent expansion. The market, which is anticipated to grow from $5.5 billion in 2024 to $5.65 billion in 2025, will do so at a compound annual growth rate (CAGR) of 2.9%. Factors such as disease prevalence, immunization initiatives, pediatric vaccination, and regulatory approvals have contributed to the growth during the historic phase.

How Big Is the Pertussis Vaccine Market Size Expected to Grow by 2029?
The market size of the pertussis vaccine is predicted to witness consistent expansion in the forthcoming years, set to rise to "$6.49 billion by 2029, with a compound annual growth rate (CAGR) of 3.5%. The forecasted growth for this period can be credited to factors such as booster vaccination, immunization for mothers, health care worker immunization, and global health campaigns. Additional trends anticipated during this forecast period comprise personalized immunization plans, combined vaccines, initiatives for equitable vaccine distribution, and the use of digital health in immunization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Key Market Drivers Powering Pertussis Vaccine Market Expansion and Growth?
The pertussis vaccine market's expansion is being propelled by increasing birth rates. The process by which a child is born is referred to as childbirth. This event signifies the culmination of pregnancy, during which the fetus grows inside the mother's womb, and the commencement of a new existence outside the uterus. The pertussis vaccine is primarily administered to children as it offers protection against severe and possibly fatal diseases such as whooping cough. As an example, a study released by the Centers for Disease Control and Prevention, a public health agency in the US, revealed that in January 2023, the US saw a 1% rise in recorded births, totaling 3,664,292, in comparison to the prior year. Hence, the accelerated birth rates are fuelling the growth of the pertussis vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pertussis Vaccine Market?
Leading firms in the pertussis vaccine market are working on the creation and approval of innovative medicines to maintain their foothold in the sector. One example is the UK-based pharma and biotech company GSK plc., which stated in October 2022 that its product, BOOSTRIX, had received approval from the U.S. Food and Drug Administration (FDA). BOOSTRIX is a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap) vaccine, administered during pregnancy to safeguard newborns against pertussis or whooping cough. It is given as a one-time shot in the upper arm muscle and has been proven to be safe and effective for both expecting women and their newborns. It is particularly effective in preventing pertussis, even in its severe forms.

What Are the Emerging Segments in the Pertussis Vaccine Market?
The pertussis vaccine market covered in this report is segmented -

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

Who Are the Global Leaders in the Pertussis Vaccine Market?
Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

Which are the Top Profitable Regional Markets for the Pertussis Vaccine Industry?
North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.